IPP Bureau

Glenmark receives ANDA approval for Apremilast Tablets
Glenmark receives ANDA approval for Apremilast Tablets

By IPP Bureau - October 18, 2023

Glenmark's current portfolio consists of 188 products authorized for distribution in the US

Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site
Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site

By IPP Bureau - October 17, 2023

Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening

Lupin enters into BTA with Lupin Manufacturing Solutions
Lupin enters into BTA with Lupin Manufacturing Solutions

By IPP Bureau - October 17, 2023

Lupin enters into BTA with Lupin Manufacturing Solutions

Satish Pandurang Samant appointed CEO of Vineet Laboratories
Satish Pandurang Samant appointed CEO of Vineet Laboratories

By IPP Bureau - October 16, 2023

He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr

Mankind Pharma appoints Prateek Dubey as President - Global CHRO
Mankind Pharma appoints Prateek Dubey as President - Global CHRO

By IPP Bureau - October 16, 2023

Prateek has more than 23 years of rich experience in Human Resource

Ipca appoints Hitesh Kumar Maheshwari as President – R&D (Formulations)
Ipca appoints Hitesh Kumar Maheshwari as President – R&D (Formulations)

By IPP Bureau - October 16, 2023

He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company

Zydus appoints Punit Patel as President and CEO, Americas
Zydus appoints Punit Patel as President and CEO, Americas

By IPP Bureau - October 16, 2023

Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace

Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines

By IPP Bureau - October 16, 2023

Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug

ImmunoACT announces the approval of India's first CAR-T cell therapy 'NexCAR19'
ImmunoACT announces the approval of India's first CAR-T cell therapy 'NexCAR19'

By IPP Bureau - October 16, 2023

NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy

Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities
Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities

By IPP Bureau - October 16, 2023

The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions

Evonik and Shandong Vland Biotech form JV in China with focus on gut health products for animals
Evonik and Shandong Vland Biotech form JV in China with focus on gut health products for animals

By IPP Bureau - October 14, 2023

Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally

Philips Visual Patient Avatar pioneers at-a-glance patient data for faster, better decision-making in the operating room
Philips Visual Patient Avatar pioneers at-a-glance patient data for faster, better decision-making in the operating room

By IPP Bureau - October 14, 2023

Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors

Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations
Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations

By IPP Bureau - October 14, 2023

The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally

Venus Remedies expands reach with the launch of Elores in Ecuador
Venus Remedies expands reach with the launch of Elores in Ecuador

By IPP Bureau - October 14, 2023

The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries

Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis
Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis

By IPP Bureau - October 13, 2023

The composition of ORAAL is protected by a granted patent in India until November 2033

Latest Stories

Interviews

Packaging